Profile data is unavailable for this security.
About the company
Meditera Tibbi Material Industry and Trade AS is a Turkey-based company, which engages in medical equipment manufacturing. The main activities of the entity consist of manufacturing and sale of medical devices (respiratory systems and infusion systems), drug preparation systems, surgical sutures (surgical sutures), biocidal products and other medical supplies. In addition to all the Company offers necessary technical service, consultancy and training. Meditera produces in its 14,840 square meter production facility with an annual capacity of 4,437 pallets and exports its products to more than 80 countries. The Company, Internacional Farmaceutica S.A. de C.V. S & Mohr company, which was established as a joint venture with (IFSA) company, manufactures surgical sutures in its facilities in Turkey, and S & Mohr America manufactures breathing circuits and accessories in its facilities in Mexico.
- Revenue in TRY (TTM)1.45bn
- Net income in TRY25.87m
- Incorporated1996
- Employees728.00
- LocationMeditera Tibbi Malzeme Sanayi ve Ticaret ASTire OSBIZMIR 35900TurkeyTUR
- Phone+90 2 325135110
- Fax+90 2 322539404
- Websitehttps://www.meditera.com.tr
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mentice AB | 804.21m | -8.28m | 2.68bn | 122.00 | -- | 5.73 | 36.43 | 3.33 | -0.1098 | -0.1098 | 10.90 | 6.22 | 0.8348 | 2.40 | 3.20 | 2,242,705.00 | -0.8595 | -7.69 | -1.69 | -13.07 | 86.39 | 83.67 | -1.03 | -10.00 | 1.01 | -- | 0.0567 | -- | 25.54 | 11.74 | 90.81 | -- | -10.83 | -- |
| OssDsign AB | 329.66m | -383.55m | 2.80bn | -- | -- | 4.05 | -- | 8.48 | -1.74 | -1.74 | 1.52 | 2.41 | 0.3408 | 6.54 | 6.19 | -- | -39.65 | -38.80 | -44.90 | -44.72 | 74.58 | 72.29 | -116.35 | -203.05 | 4.15 | -30.39 | 0.0132 | -- | 96.82 | 53.26 | -31.30 | -- | -60.35 | -- |
| Integrum AB | 282.73m | 24.27m | 2.99bn | 34.00 | 127.96 | 7.16 | 98.18 | 10.58 | 0.447 | 0.447 | 5.19 | 7.99 | 0.5918 | 0.5859 | 3.83 | -- | 5.08 | -6.65 | 5.65 | -7.95 | 86.80 | 81.52 | 8.58 | -11.19 | 3.04 | -4.28 | 0.0462 | -- | 33.29 | 37.39 | -117.50 | -- | 86.42 | -- |
| Carmat SA | 30.93m | -1.88bn | 3.03bn | 177.00 | -- | -- | -- | 97.95 | -2.25 | -2.25 | 0.0369 | -0.3817 | 0.0123 | 1.58 | 0.2029 | 5,000.00 | -74.73 | -76.92 | -89.51 | -93.77 | -3,232.74 | -- | -6,074.19 | -9,203.39 | 2.81 | -14.25 | 1.18 | -- | -84.52 | -- | 13.24 | -- | -10.97 | -- |
| Optomed Oyj | 521.89m | -153.46m | 3.13bn | 114.00 | -- | 4.37 | -- | 6.00 | -0.2695 | -0.2695 | 0.9211 | 1.15 | 0.5002 | 1.67 | 4.92 | 132,456.10 | -14.70 | -12.95 | -17.72 | -15.90 | 67.83 | 65.69 | -29.40 | -27.84 | 2.04 | -7.29 | 0.1926 | -- | 3.00 | 3.47 | 18.84 | -- | 7.26 | -- |
| Mercator Medical SA | 3.75bn | -1.85bn | 3.61bn | 1.29k | -- | 0.4607 | -- | 0.9631 | -23.80 | -23.80 | 48.72 | 92.24 | 0.4125 | 2.54 | 5.35 | 363,078.80 | -20.75 | 29.67 | -22.11 | 36.78 | 0.4885 | 38.55 | -50.30 | 23.59 | 5.67 | -40.08 | 0.006 | 2.49 | -68.59 | 12.52 | -142.43 | -- | 8.36 | -- |
| Meditera Tibbi Mlzm Sny Tcrt AS | 1.45bn | 25.87m | 3.75bn | 728.00 | 144.92 | 2.51 | 47.17 | 2.58 | 0.2174 | 0.2174 | 12.20 | 12.53 | 0.7678 | 2.92 | 5.31 | 1,994,873.00 | 1.37 | 9.37 | 1.59 | 11.54 | 44.33 | 43.51 | 1.78 | 9.85 | 2.83 | -- | 0.0552 | 181.79 | -8.99 | 48.75 | -77.38 | 15.68 | -- | -- |
| C Rad AB | 1.25bn | 104.13m | 3.82bn | 87.00 | 37.57 | 4.91 | 29.11 | 3.06 | 1.05 | 1.05 | 12.57 | 8.03 | 1.14 | 4.42 | 3.82 | 4,880,632.00 | 9.60 | 5.09 | 13.75 | 7.02 | 45.83 | 43.12 | 8.41 | 4.86 | 2.27 | 139.13 | 0.0064 | 0.00 | 40.92 | 17.44 | 375.05 | 10.89 | 33.69 | -- |
| Oncosem Onkolojik Sistemlr Sny v Tcrt AS | 240.51m | -79.81m | 4.20bn | 324.00 | -- | 18.15 | -- | 17.48 | -3.44 | -3.44 | 10.15 | 9.72 | 0.6993 | 2.47 | 3.93 | 742,302.40 | -23.20 | -- | -31.86 | -- | 14.88 | -- | -33.18 | -- | 1.30 | -- | 0.2087 | -- | -17.90 | -- | -284.37 | -- | -- | -- |
| Bastide Le Confort Medical SA | 18.09bn | 218.33m | 4.57bn | 3.55k | 24.66 | 1.63 | 1.61 | 0.2529 | 0.7299 | 0.772 | 65.57 | 11.02 | 0.7955 | 5.44 | 6.90 | 147,580.70 | 1.84 | 2.49 | 2.66 | 3.52 | 50.54 | 48.82 | 2.31 | 3.05 | 0.811 | 1.92 | 0.8391 | -- | 8.48 | 11.94 | 11.24 | 17.55 | 6.98 | -- |
| ADDvise Group AB (publ) | 4.34bn | 325.67m | 4.76bn | 620.00 | 23.36 | 3.27 | 7.22 | 1.10 | 0.5864 | 0.5864 | 7.84 | 4.20 | 0.5506 | 6.73 | 5.52 | 2,365,224.00 | 4.14 | 3.72 | 5.17 | 4.77 | 47.63 | 48.95 | 7.51 | 5.89 | 1.09 | 2.99 | 0.6608 | 0.9405 | 44.30 | 38.62 | 27.62 | -- | 30.35 | -- |
| Amplitude Surgical SA | 3.60bn | 1.49bn | 4.85bn | 416.00 | 3.24 | 1.48 | 2.56 | 1.35 | 0.9002 | 0.9002 | 2.17 | 1.97 | 0.3955 | 0.5652 | 8.83 | 244,244.10 | 16.21 | -0.3658 | 19.44 | -0.4267 | 79.41 | 78.30 | 40.98 | -1.08 | 1.21 | 0.4163 | 0.5395 | -- | 14.44 | -0.0271 | 993.58 | -- | 7.11 | -- |
| Pulsion Medical Systems SE | 1.09bn | 186.85m | 4.99bn | 66.00 | 26.72 | 5.21 | 21.22 | 4.56 | 0.6549 | 0.6549 | 3.84 | 3.36 | 0.9711 | 1.77 | 3.88 | 479,840.00 | 16.58 | 20.37 | 21.24 | 31.17 | 63.66 | 55.96 | 17.07 | 24.12 | 1.77 | 15.74 | 0.00 | 1,227.72 | 6.10 | 3.02 | -8.06 | -- | -- | 0.00 |
Data as of Apr 30 2024. Currency figures normalised to Meditera Tibbi Malzeme Sanayi ve Ticaret AS's reporting currency: Turkish Lira TRY
0.47%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| HSBC Portf�y Y�netim ASas of 29 Feb 2024 | 544.70k | 0.46% |
| IS Portfoy Yonetimi ASas of 31 Jul 2021 | 15.68k | 0.01% |
Data from 31 Dec 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
